121,662 Shares in CVS Health Corporation $CVS Purchased by One Way Holdings LLC

One Way Holdings LLC purchased a new stake in CVS Health Corporation (NYSE:CVS) in the 3rd quarter, according to its most recent filing with the SEC. The fund purchased 121,662 shares of the pharmacy operator’s stock, valued at approximately $10,425,000.

Other large investors also recently made changes to their positions in the company. Elevation Wealth Partners LLC grew its position in shares of CVS Health by 41.8% in the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 105 shares during the period. HBW Advisory Services LLC lifted its position in CVS Health by 3.5% during the third quarter. HBW Advisory Services LLC now owns 3,408 shares of the pharmacy operator’s stock worth $292,000 after buying an additional 115 shares during the period. Apella Capital LLC boosted its stake in CVS Health by 1.7% in the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock worth $724,000 after buying an additional 117 shares during the last quarter. Wellington Altus USA Inc. boosted its stake in CVS Health by 13.3% in the 2nd quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock worth $106,000 after buying an additional 120 shares during the last quarter. Finally, Childress Capital Advisors LLC grew its holdings in CVS Health by 3.9% in the 3rd quarter. Childress Capital Advisors LLC now owns 3,497 shares of the pharmacy operator’s stock valued at $300,000 after buying an additional 131 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.1%

CVS stock opened at $90.20 on Monday. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a market capitalization of $115.36 billion, a price-to-earnings ratio of 23.86, a price-to-earnings-growth ratio of 0.84 and a beta of 0.58. The firm’s 50-day moving average is $91.22 and its two-hundred day moving average is $88.76. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The business’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be issued a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Thursday, October 22nd. CVS Health’s dividend payout ratio is presently 70.37%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CVS. Piper Sandler set a $112.00 price objective on shares of CVS Health in a report on Wednesday, September 9th. Cantor Fitzgerald restated a “neutral” rating on shares of CVS Health in a research note on Friday, October 9th. HSBC reaffirmed a “hold” rating and set a $103.00 price target on shares of CVS Health in a research report on Monday, July 6th. Wall Street Zen downgraded shares of CVS Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 19th. Finally, Weiss Ratings lowered CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 9th. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $109.64.

CVS Health Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.